Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Brent Egan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Risk Factors

Chemicals & Drugs

Procedures

Sodium-Restricted Diet

Geographic Areas

South Carolina

Physiology

Living Beings

European Continental Ancestry Group

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
35
Lackland, Daniel
20
Goodfriend, Theodore
20
Stepniakowski, KT
14
Julius, Stevo
12
Basile, Jan
9
King, Dana
8
Weder, Alan
8
Mainous, Arch
7
Lopes, Heno
7
Lu, G
7
Hendrix, Katharine
6
Greene, Eddie
6
Geesey, Mark
6
Nesbitt, Shawna
6
Okonofua, Eni

Sign-in to see all Coauthors

Publications

TOP 3
Egan Brent M; Basile Jan N; Rehman Shakaib U; Davis Phillip B; Grob Curt H; Riehle Jessica Flynn; Walters Christine A; Lackland Daniel T; Merali Carmen; Sealey Jean E; Laragh John H
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
Egan Brent M
Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle.
Egan Brent M
Sleep-disordered breathing and blood pressure in children.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Brent Egan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Egan Brent M; Basile Jan N; Rehman Shakaib U; Davis Phillip B; Grob Curt H; Riehle Jessica Flynn; Walters Christine A; Lackland Daniel T; Merali Carmen; Sealey Jean E; Laragh John H
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
American journal of hypertension 2009;22(7):792-801.
2009: Egan Brent M
Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle.
Hypertension 2009;53(4):598-9.
2008: Egan Brent M
Sleep-disordered breathing and blood pressure in children.
Hypertension 2008;52(5):807.
2008: Egan Brent M; Julius Stevo
Prehypertension: risk stratification and management considerations.
Current hypertension reports 2008;10(5):359-66.
2008: Lackland Daniel T; Egan Brent M
Sodium intake and mortality: the debate continues.
Journal of general internal medicine 2008;23(9):1537-8.
2008: Egan Brent M; Nesbitt Shawna D; Julius Stevo
Prehypertension: should we be treating with pharmacologic therapy?
Therapeutic advances in cardiovascular disease 2008;2(4):305-14.
2008: Moser Marvin; Houston Mark; Svetkey Laura; Egan Brent
Dietary management in the prevention and treatment of hypertension: does it work?
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(8):632-9.
2008: Williams Setareh A; Michelson Eric L; Cain Valerie A; Yang Min; Nesbitt Shawna D; Egan Brent M; Julius Stevo;
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY).
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(6):436-42.
2008: King Dana E; Mainous Arch G; Egan Brent M; Woolson Robert F; Geesey Mark E
Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM).
Annals of family medicine 2008;6(2):100-6.
2008: Andersen Karl; Weinberger Myron H; Egan Brent; Constance Christian M; Ali Mohammed A; Jin James; Keefe Deborah L
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Journal of hypertension 2008;26(3):589-99.
2008: Abell Jill E; Egan Brent M; Wilson Peter W F; Lipsitz Stuart; Woolson Robert F; Lackland Daniel T
Differences in cardiovascular disease mortality associated with body mass between Black and White persons.
American journal of public health 2008;98(1):63-6.
2007: Egan Brent M
Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(10):783-9.
2007: King Dana E; Mainous Arch G; Egan Brent M; Player Marty; Geesey Mark E
Use of statins and blood pressure.
American journal of hypertension 2007;20(9):937-41.
2007: Lackland Daniel T; Egan Brent M
Dietary salt restriction and blood pressure in clinical trials.
Current hypertension reports 2007;9(4):314-9.
2007: Abell Jill E; Egan Brent M; Wilson Peter W F; Lipsitz Stuart; Woolson Robert F; Lackland Daniel T
Age and race impact the association between BMI and CVD mortality in women.
Public health reports (Washington, D.C. : 1974) 2007;122(4):507-12.
2007: King Dana E; Egan Brent M; Woolson Robert F; Mainous Arch G; Al-Solaiman Yaser; Jesri Ammar
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level.
Archives of internal medicine 2007;167(5):502-6.
2007: Julius Stevo; Schork Anthony; Egan Brent M
From TROPHY with pride.
American journal of hypertension 2007;20(3):342-3; author reply 343-5.
2007: Fan Z Joyce; Lackland Daniel T; Lipsitz Stuart R; Nicholas Joyce S; Egan Brent M; Tim Garvey W; Hutchison Florence N
Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina.
Health & place 2007;13(1):179-87.
2007: Gilliard Theodosha S; Lackland Daniel T; Mountford William K; Egan Brent M
Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women.
Ethnicity & disease 2007;17(4):617-23.
2006: Egan Brent M; Lackland Daniel T; Igho-Pemu Priscilla; Hendrix Katharine H; Basile Jan; Rehman Shakaib U; Okonofua Eni C; Quarshie Alexander; Oduwole Adefisayo; Onwuanyi Anekwe; Reed James; Obialo Chamberlain; Ofili Elizabeth O
Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):879-86.
2006: Lopes Heno Ferreira; Egan Brent M
Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic.
Arquivos brasileiros de cardiologia 2006;87(4):538-47.
2006: Messerli Franz H; Bangalore Sripal; Egan Brent M; Julius Stevo
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
The American journal of cardiology 2006;98(8):1122.
2006: Gadegbeku Crystal A; Shrayyef M Zakarea; Taylor Timothy P; Egan Brent M
Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension.
Journal of hypertension 2006;24(7):1383-9.
2006: Egan Brent M
Sleep and hypertension: burning the candle at both ends really is hazardous to your health.
Hypertension 2006;47(5):816-7.
2006: King Dana E; Egan Brent M; Mainous Arch G; Geesey Mark E
The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(4):257-60.
2006: Julius Stevo; Nesbitt Shawna D; Egan Brent M; Weber Michael A; Michelson Eric L; Kaciroti Niko; Black Henry R; Grimm Richard H; Messerli Franz H; Oparil Suzanne; Schork M Anthony;
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
The New England journal of medicine 2006;354(16):1685-97.
2006: Okonofua Eni C; Simpson Kit N; Jesri Ammar; Rehman Shakaib U; Durkalski Valerie L; Egan Brent M
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.
Hypertension 2006;47(3):345-51.
2006: Miller Peter M; Spies Claudia; Neumann Tim; Javors Martin A; Hoyumpa A M; Roache John; Webb Amy; Kashi Maryam; Sharkey Francis E; Anton Raymond F; Egan Brent M; Basile Jan; Nguyen Shaun; Fleming Michael F; Dillie Kathryn Sullivan
Alcohol biomarker screening in medical and surgical settings.
Alcoholism, clinical and experimental research 2006;30(2):185-93.
2006: Egan Brent M
Challenges and risks in attaining the systolic blood pressure goal of <130 mm Hg in all diabetic patients.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(1):50-2.
2005: Jesri Ammar; Okonofua Eni C; Egan Brent M
Platelet and white blood cell counts are elevated in patients with the metabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(12):705-11; quiz 712-3.
2005: Coffee Robert E; Nicholas Joyce S; Egan Brent M; Rumboldt Zoran; D'Agostino Sabino; Patel Sunil J
Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis.
Journal of hypertension 2005;23(11):2027-31.
2005: Hendrix Katharine H; Mayhan Susan; Lackland Daniel T; Egan Brent M
Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients.
American journal of hypertension 2005;18(8):1026-32.
2005: Riehle Jessica Flynn; Lackland Daniel T; Okonofua Eni C; Hendrix Katherine H; Egan Brent M
Ethnic differences in the treatment and control of hypertension in patients with diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(8):445-54.
2005: Nesbitt Shawna D; Julius Stevo; Leonard David; Egan Brent M; Grozinski Melissa;
Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study.
American journal of hypertension 2005;18(7):980-5.
2005: Okonofua Eni C; Cutler Neal E; Lackland Daniel T; Egan Brent M
Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension.
American journal of hypertension 2005;18(7):972-9.
2005: Liszka Heather A; Mainous Arch G; King Dana E; Everett Charles J; Egan Brent M
Prehypertension and cardiovascular morbidity.
Annals of family medicine 2005;3(4):294-9.
2005: Egan Brent M; Basile Jan; Chilton Robert J; Cohen Jerome D
Cardioprotection: the role of beta-blocker therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(7):409-16.
2005: Hendrix Katherine H; Mayhan Susan; Egan Brent M
Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(7):386-94.
2005: Miller Peter M; Anton Raymond F; Egan Brent M; Basile Jan; Nguyen Shaun A
Excessive alcohol consumption and hypertension: clinical implications of current research.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):346-51.
2005: Bestermann William; Houston Mark C; Basile Jan; Egan Brent; Ferrario Carlos M; Lackland Dan; Hawkins Ralph G; Reed James; Rogers Philip; Wise Daniel; Moore Michael A
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
The American journal of the medical sciences 2005;329(6):292-305.
2005: Houston Mark C; Basile Jan; Bestermann William H; Egan Brent; Lackland Daniel; Hawkins Ralph G; Moore Michael A; Reed James; Rogers Philip; Wise Daniel; Ferrario Carlos M
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
The American journal of the medical sciences 2005;329(6):276-91.
2005: King Dana E; Mainous Arch G; Egan Brent M; Woolson Robert F; Geesey Mark E
Fiber and C-reactive protein in diabetes, hypertension, and obesity.
Diabetes care 2005;28(6):1487-9.
2005: Rehman Shakaib U; Hutchison Florence N; Hendrix Katharine; Okonofua Eni C; Egan Brent M
Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites.
Archives of internal medicine 2005;165(9):1041-7.
2005: Standridge J B; Sealey J E; Laragh J H; Houston M C; Gavras H; Johnson R J; Blumenfeld J D; Brown M; Egan B M; Meltzer J I; Shimosawa T; Fujita T
A free-ranging roundtable discussion on hypertension.
Journal of human hypertension 2005;19(4):259-66.
2005: Egan Brent M; Papademetriou Vasilios; Wofford Marion; Calhoun David; Fernandes Jyotika; Riehle Jessica E; Nesbitt Shawna; Michelson Eric; Julius Stevo;
Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
American journal of hypertension 2005;18(1):3-12.
2005: Sheats Nina; Lin Yan; Zhao Wenle; Cheek DeAnna E; Lackland Daniel T; Egan Brent M
Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients.
Ethnicity & disease 2005;15(1):25-32.
2005: Hendrix Katharine H; Riehle Jessica E; Egan Brent M
Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients.
Ethnicity & disease 2005;15(1):11-6.
2004: Egan Brent; Gleim Gilbert; Panish Jessica
Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.
Current medical research and opinion 2004;20(12):1909-17.
2004: Mainous Arch G; Everett Charles J; Liszka Heather; King Dana E; Egan Brent M
Prehypertension and mortality in a nationally representative cohort.
The American journal of cardiology 2004;94(12):1496-500.
2004: Bestermann William H; Lackland Daniel T; Riehle Jessica E; Egan Brent M
A systematic approach to managing hypertension and the metabolic syndrome in primary care.
Southern medical journal 2004;97(10):932-8.
2004: King Dana E; Egan Brent M; Mainous Arch G; Geesey Mark E
Elevation of C-reactive protein in people with prehypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(10):562-8.
2004: Egan Brent M
Hypertension in the 21st century: the tide is rising; our daze must end.
Hypertension 2004;44(4):389.
2004: Gadegbeku Crystal A; Shrayyef M Zakarea; LaPorte Frankie B; Egan Brent M
Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(3):446-54.
2004: Julius Stevo; Nesbitt Shawna; Egan Brent; Kaciroti Niko; Schork M Anthony; Grozinski Melissa; Michelson Eric;
Trial of preventing hypertension: design and 2-year progress report.
Hypertension 2004;44(2):146-51.
2004: Nashar Khaled; Nguyen Jacqueline P; Jesri Ammar; Morrow Jason D; Egan Brent M
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
American journal of hypertension 2004;17(6):477-82.
2004: Goodfriend Theodore L; Ball Dennis L; Egan Brent M; Campbell William B; Nithipatikom Kasem
Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion.
Hypertension 2004;43(2):358-63.
2004: Lackland Daniel T; Lin Yan; Tilley Barbara C; Egan Brent M
An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(1):26-31; quiz 32-3.
2004: Basile Jan N; Lackland Daniel T; Basile Jeffrey M; Riehle Jessica E; Egan Brent M
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(1):18-25.
2003: Egan Brent M; Chilton Robert J
Other important applications for beta-blockers in high-risk patients.
Postgraduate medicine 2003;114(6 Suppl Role):35-48.
2003: Egan Brent M
Beta-blockers for cardioprotection. A forgotten message?
Postgraduate medicine 2003;114(6 Suppl Role):3.
2003: King Dana E; Egan Brent M; Geesey Mark E
Relation of dietary fat and fiber to elevation of C-reactive protein.
The American journal of cardiology 2003;92(11):1335-9.
2003: Egan Brent M; Basile Jan N
Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report?
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2003;51(6):373-85.
2003: Hendrix Katharine H; Lackland Daniel T; Egan Brent M
Cardiovascular risk factor control and treatment patterns in primary care.
Managed care interface 2003;16(11):21-6.
2003: Egan Brent M
Reproducibility of BP responses to changes in dietary salt: compelling evidence for universal sodium restriction?
Hypertension 2003;42(4):457-8.
2003: Giese Melanie; Lackland Daniel; Basile Jan; Egan Brent
2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health.
Journal of the South Carolina Medical Association (1975) 2003;99(6):157-61.
2003: Egan Brent M
Insulin resistance and the sympathetic nervous system.
Current hypertension reports 2003;5(3):247-54.
2003: Lopes Heno F; Morrow Jason D; Stojiljkovic Milos P; Goodfriend Theodore L; Egan Brent M;
Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans.
American journal of hypertension 2003;16(5 Pt 1):331-6.
2003: Lackland D T; Egan B M; Ferguson P L
Low birth weight as a risk factor for hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(2):133-6.
2003: Egan Brent M; Lackland Daniel T; Cutler Neal E
Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research.
Archives of internal medicine 2003;163(6):681-7.
2003: Lopes Heno F; Martin Kelley L; Nashar Khaled; Morrow Jason D; Goodfriend Theodore L; Egan Brent M
DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity.
Hypertension 2003;41(3):422-30.
2003: Gadegbeku Crystal A; Dhandayuthapani Arachelvi; Shrayyef M Zakaria; Egan Brent M
Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects.
American journal of hypertension 2003;16(1):67-71.
2002: Bakris George; Calhoun David; Egan Brent; Hellmann Christopher; Dolker Michael; Kingma Iris;
Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.
Journal of hypertension 2002;20(11):2257-67.
2002: Egan Brent M
Ethnicity and unprovoked hypokalemia in the ARIC Study.
American journal of hypertension 2002;15(7 Pt 1):660-1.
2002: Gadegbeku Crystal A; Dhandayuthapani Arachelvi; Sadler Zara E; Egan Brent M
Raising lipids acutely reduces baroreflex sensitivity.
American journal of hypertension 2002;15(6):479-85.
2002: Stojiljkovic Milos P; Lopes Heno F; Zhang Da; Morrow Jason D; Goodfriend Theodore L; Egan Brent M
Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.
Journal of hypertension 2002;20(6):1215-21.
2002: Lopes H F; Stojiljkovic M P; Zhang D; Goodfriend T L; Egan B M
Moderate sodium restriction enhances the pressor response to hyperlipidemia in obese, hypertensive patients.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(3):173-80.
2002: Egan Brent M; Lackland Daniel T; Basile Jan N
American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community.
American journal of hypertension 2002;15(4 Pt 1):372-9.
2002: Lackland Daniel T; Egan Brent M; Syddall Holly E; Barker David J P
Associations between birth weight and antihypertensive medication in black and white medicaid recipients.
Hypertension 2002;39(1):179-83.
2002: Foster Kim Y; Diehl Nancy S; Shaw Darlene; Rogers Rebecca L; Egan Brent; Carek Peter; Tomsic Jim
Medical students' readiness to provide lifestyle counseling for overweight patients.
Eating behaviors 2002;3(1):1-13.
2001: Lopes H F; Stojiljkovic M P; Zhang D; Goodfriend T L; Egan B M
The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents.
American journal of hypertension 2001;14(10):1032-7.
2001: Haastrup A; Gadegbeku C A; Zhang D; Mukhin Y V; Greene E L; Jaffa A A; Egan B M
Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins.
Hypertension 2001;38(4):858-63.
2001: Egan B M; Lackland D T; Williams B; Gunter N; Tocharoen A; Beardon L
Health care improvement and cost reduction opportunities in hypertensive Medicaid beneficiaries.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):279-82, 318.
2001: Egan B M; Greene E L; Goodfriend T L
Insulin resistance and cardiovascular disease.
American journal of hypertension 2001;14(6 Pt 2):116S-125S.
2001: Stojiljkovic M P; Zhang D; Lopes H F; Lee C G; Goodfriend T L; Egan B M
Hemodynamic effects of lipids in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(6):R1674-9.
2001: Egan B M; Greene E L; Goodfriend T L
Nonesterified fatty acids in blood pressure control and cardiovascular complications.
Current hypertension reports 2001;3(2):107-16.
2001: Giese M; Lackland D T; Egan B M
The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control.
Journal of the South Carolina Medical Association (1975) 2001;97(2):57-62.
2001: Greene E L; Lu G; Zhang D; Egan B M
Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration.
Hypertension 2001;37(2):308-12.
2001: Lackland D T; Egan B M; Fan Z J; Syddall H E
Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(1):29-31.
2001: Oexmann M J; Ascanio R; Egan B M
Efficacy of a church-based intervention on cardiovascular risk reduction.
Ethnicity & disease 2001;11(4):817-22.
2000: Egan B M; Lackland D T
Biochemical and metabolic effects of very-low-salt diets.
The American journal of the medical sciences 2000;320(4):233-9.
2000: Gajjar D; Egan B; Curè J; Rust P; VanTassel P; Patel S J
Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension.
Hypertension 2000;36(1):78-82.
2000: Lackland D T; Bendall H E; Osmond C; Egan B M; Barker D J
Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States.
Archives of internal medicine 2000;160(10):1472-6.
2000: Oexmann M J; Thomas J C; Taylor K B; O'Neil P M; Garvey W T; Lackland D T; Egan B M
Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans.
Ethnicity & disease 2000;10(1):17-23.
1999: Lackland D T; Egan B M
The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States.
The American journal of the medical sciences 1999;318(6):365-8.
1999: Jones D; Basile J; Cushman W; Egan B; Ferrario C; Hill M; Lackland D; Mensah G; Moore M; Ofili E; Roccella E J; Smith R; Taylor H
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI).
The American journal of the medical sciences 1999;318(6):357-64.
1999: Lackland D T; Egan B M; Jones P J
Impact of nativity and race on "Stroke Belt" mortality.
Hypertension 1999;34(1):57-62.
1999: Egan B M; Lu G; Greene E L
Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(5-6):411-20.
1999: Goodfriend T L; Egan B M; Kelley D E
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(5-6):401-5.
1998: Lu G; Greene E L; Nagai T; Egan B M
Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells.
Hypertension 1998;32(6):1003-10.
1998: Haastrup A T; Stepniakowski K T; Goodfriend T L; Egan B M
Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity.
Hypertension 1998;32(4):693-8.
1998: Goodfriend T L; Egan B M; Kelley D E
Aldosterone in obesity.
Endocrine research 1998;24(3-4):789-96.
1998: Barone B M; Egan B M; Brown T E; Resch M L; Woodard L J; Trogdon K P; Lackland D T
Commun-I-Care: experience in the first four years.
Journal of the South Carolina Medical Association (1975) 1998;94(7):318-22.
1998: Lu G; Meier K E; Jaffa A A; Rosenzweig S A; Egan B M
Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells.
Hypertension 1998;31(4):978-85.
1998: Egan B M; Lackland D T
Strategies for cardiovascular disease prevention: importance of public and community health programs.
Ethnicity & disease 1998;8(2):228-39.
1997: Stepniakowski K T; Lu G; Davda R K; Egan B M
Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism.
Hypertension 1997;30(6):1634-9.
1997: Stepniakowski K T; Lu G; Miller G D; Egan B M
Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins.
Hypertension 1997;30(5):1150-5.
1997: Goodfriend T L; Egan B M
Nonesterified fatty acids in the pathogenesis of hypertension: theory and evidence.
Prostaglandins, leukotrienes, and essential fatty acids 1997;57(1):57-63.
1997: Hall W D; Ferrario C M; Moore M A; Hall J E; Flack J M; Cooper W; Simmons J D; Egan B M; Lackland D T; Perry M; Roccella E J
Hypertension-related morbidity and mortality in the southeastern United States.
The American journal of the medical sciences 1997;313(4):195-209.
1997: Egan B M; Stepniakowski K T
Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering.
The American journal of clinical nutrition 1997;65(2 Suppl):671S-677S.
1997: McCarron D A; Weder A B; Egan B M; Krishna G G; Morris C D; Cohen M; Oparil S
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients.
American journal of hypertension 1997;10(1):68-76.
1996: Lu G; Morinelli T A; Meier K E; Rosenzweig S A; Egan B M
Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C.
Circulation research 1996;79(3):611-8.
1996: Alexander C N; Schneider R H; Staggers F; Sheppard W; Clayborne B M; Rainforth M; Salerno J; Kondwani K; Smith S; Walton K G; Egan B
Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis.
Hypertension 1996;28(2):228-37.
1996: Hennes M M; O'Shaughnessy I M; Kelly T M; LaBelle P; Egan B M; Kissebah A H
Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system.
Hypertension 1996;28(1):120-6.
1996: Stepniakowski K T; Sallee F R; Goodfriend T L; Zhang Z; Egan B M
Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors.
The American journal of physiology 1996;270(6 Pt 2):R1340-6.
1996: Ullian M E; Hazen-Martin D J; Walsh L G; Davda R K; Egan B M
Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings.
Hypertension 1996;27(6):1346-52.
1996: Egan B M; Hennes M M; Stepniakowski K T; O'Shaughnessy I M; Kissebah A H; Goodfriend T L
Obesity hypertension is related more to insulin's fatty acid than glucose action.
Hypertension 1996;27(3 Pt 2):723-8.
1995: Davda R K; Stepniakowski K T; Lu G; Ullian M E; Goodfriend T L; Egan B M
Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism.
Hypertension 1995;26(5):764-70.
1995: O'Shaughnessy I M; Myers T J; Stepniakowski K; Nazzaro P; Kelly T M; Hoffmann R G; Egan B M; Kissebah A H
Glucose metabolism in abdominally obese hypertensive and normotensive subjects.
Hypertension 1995;26(1):186-92.
1995: Kjeldsen S E; Weder A B; Egan B; Neubig R; Zweifler A J; Julius S
Effect of circulating epinephrine on platelet function and hematocrit.
Hypertension 1995;25(5):1096-105.
1995: Stepniakowski K T; Goodfriend T L; Egan B M
Fatty acids enhance vascular alpha-adrenergic sensitivity.
Hypertension 1995;25(4 Pt 2):774-8.
1995: Stepniakowski K; Egan B M
Additive effects of obesity and hypertension to limit venous volume.
The American journal of physiology 1995;268(2 Pt 2):R562-8.
1995: Goodfriend T L; Egan B; Stepniakowski K; Ball D L
Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans.
Hypertension 1995;25(1):30-6.
1994: Kenny D; Egan B M
Is there a role for dietary fish oil in the treatment of hypertension?
Journal of human hypertension 1994;8(12):895-905.
1994: Egan B M; Stepniakowski K; Goodfriend T L
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
American journal of hypertension 1994;7(10 Pt 1):886-93.
1994: Egan B M; Stepniakowski K
Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives.
Journal of hypertension 1994;12(9):1061-7.
1994: Nazzaro P; Stepniakowski K; O'Shaughnessy I M; Kissebah A H; Egan B M
Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night.
American journal of hypertension 1994;7(7 Pt 1):609-14.
1994: Egan B M; Stepniakowski K; Nazzaro P
Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects.
Hypertension 1994;23(1 Suppl):I1-7.
1994: Egan B M; Stepniakowski K; Zweifler A J
Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects.
Journal of human hypertension 1994;8(1):59-64.
1993: Neahring J M; Stepniakowski K; Greene A S; Egan B M
Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men.
Hypertension 1993;22(4):584-90.
1993: Egan B M; Fleissner M J; Stepniakowski K; Neahring J M; Sagar K B; Ebert T J
Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone.
Journal of hypertension 1993;11(10):1113-20.
1993: Egan B M; Stepniakowski K
Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension.
The American journal of cardiology 1993;72(1):53-7.
1993: Shin H H; Sagar K B; Stepniakowski K; Wetherbee J N; Egan B M
Increased prevalence of abnormal signal-averaged electrocardiograms in older patients who have hypertension with low diastolic blood pressure.
American heart journal 1993;125(6):1698-703.
1992: Kenny D; Warltier D C; Pleuss J A; Hoffmann R G; Goodfriend T L; Egan B M
Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men.
The American journal of cardiology 1992;70(15):1347-52.
1992: Egan B M
Hypertension, diuretics, and coronary heart disease: a case of apples and oranges, reciprocal prejudice, and a partially-clad emperor?
American journal of hypertension 1992;5(9):665-6.
1992: Sorokin G; Grant N M; Egan B M; Lombard J H
Cyclooxygenase products do not modulate angiotensin II-induced contractions of human chorionic plate arteries.
American journal of obstetrics and gynecology 1992;167(1):110-4.
1992: Egan B M
Adaptive changes in cerebral blood vessels during chronic hypertension.
Journal of hypertension 1992;10(4):399-400.
1992: Egan B
Cardiovascular risk factors, clustering and complications in overweight young men.
Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting 1992;():107-15.
1991: Egan B M; Petrin J; Hoffmann R G
NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men.
American journal of hypertension 1991;4(12 Pt 1):924-31.
1991: Egan B M
Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture.
International journal of obesity 1991;15 Suppl 2():133-9.
1991: Goodfriend T L; Ball D L; Weinberger M H; Moore T J; Weder A B; Egan B M
Salt loads raise plasma fatty acids and lower insulin.
Hypertension 1991;17(6 Pt 2):958-64.
1991: Egan B M; Weder A B; Petrin J; Hoffman R G
Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status.
American journal of hypertension 1991;4(5 Pt 1):416-21.
1991: Egan B M; Bassett D R; Block W D
Comparative effects of overweight on cardiovascular risk in younger versus older men.
The American journal of cardiology 1991;67(4):248-52.
1991: Weder A B; Egan B M
Potential deleterious impact of dietary salt restriction on cardiovascular risk factors.
Klinische Wochenschrift 1991;69 Suppl 25():45-50.
1990: Sekkarie M A; Egan B M; Neubig R R; Supiano M A
Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate.
Clinical pharmacology and therapeutics 1990;48(5):537-43.
1990: Mejia A D; Egan B M; Schork N J; Zweifler A J
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension.
Annals of internal medicine 1990;112(4):270-7.
1989: Egan B M
Neurogenic mechanisms initiating essential hypertension.
American journal of hypertension 1989;2(12 Pt 2):357S-362S.
1989: Petrin J; Egan B M; Julius S
Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S78-9.
1989: Egan B; Fitzpatrick M A; Juni J; Buda A J; Zweifler A
Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension.
The American journal of cardiology 1989;64(12):752-5.
1989: Egan B M; Schork N J; Weder A B
Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses.
American journal of hypertension 1989;2(6 Pt 1):428-34.
1989: Dananberg J; Egan B M; Bates E R; Grekin R J
Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch.
The Journal of clinical endocrinology and metabolism 1989;68(4):735-9.
1988: Weder A B; Egan B M
Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans.
Hypertension 1988;12(2):199-203.
1988: Egan B; Schmouder R
The importance of hemodynamic considerations in essential hypertension.
American heart journal 1988;116(2 Pt 2):594-9.
1988: Egan B; Conlon M E; Campbell R; Schork N; Zwiefler A; Julius S
Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.
American journal of hypertension 1988;1(3 Pt 3):324S-330S.
1988: Egan B; Schork N; Panis R; Hinderliter A
Vascular structure enhances regional resistance responses in mild essential hypertension.
Journal of hypertension 1988;6(1):41-8.
1987: Egan B; Panis R; Hinderliter A; Schork N; Julius S
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.
The Journal of clinical investigation 1987;80(3):812-7.
1987: Weder A B; Fitzpatrick M A; Torretti B A; Hinderliter A L; Egan B M; Julius S
Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension.
Hypertension 1987;9(5):459-66.
1987: Egan B; Fitzpatrick M A; Julius S
The heart and the regulation of renin.
Circulation 1987;75(1 Pt 2):I130-3.
1986: Fitzpatrick M A; Hinderliter A L; Egan B M; Julius S
Decreased venous distensibility and reduced renin responsiveness in hypertension.
Hypertension 1986;8(6 Pt 2):II36-43.
1986: Schneider R H; Egan B M; Johnson E H; Drobny H; Julius S
Anger and anxiety in borderline hypertension.
Psychosomatic medicine 1986;48(3-4):242-8.
1986: Egan B
Management of the patient with borderline hypertension.
Journal of cardiovascular pharmacology 1986;8 Suppl 5():S103-7.
1985: Egan B; Neubig R; Julius S
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number.
Clinical pharmacology and therapeutics 1985;38(5):519-24.
1985: Egan B
Nutritional and lifestyle approaches to the prevention and management of hypertension.
Comprehensive therapy 1985;11(8):15-20.
1985: Egan B; Julius S
Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive.
Clinical and experimental hypertension. Part A, Theory and practice 1985;7(2-3):243-55.
1985: Egan B; Neubig R; Schneider R H; Julius S
Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans.
Journal of cardiovascular pharmacology 1985;7 Suppl 6():S153-8.
1984: Egan B; Grekin R; Ibsen H; Osterziel K; Julius S
Role of cardiopulmonary mechanoreceptors in ADH release in normal humans.
Hypertension 1984;6(6 Pt 1):832-6.
1983: Egan B M; Julius S; Cottier C; Osterziel K J; Ibsen H
Role of cardiovascular receptors on the neural regulation of renin release in normal men.
Hypertension 1983;5(5):779-86.
1983: Julius S; Cottier C; Egan B; Ibsen H; Kiowski W
Cardiopulmonary mechanoreceptors and renin release in humans.
Federation proceedings 1983;42(10):2703-8.
1983: Egan B; Julius S
Borderline hypertension.
Primary care 1983;10(1):99-113.
1983: Ibsen H; Egan B; Osterziel K; Vander A; Julius S
Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans.
Hypertension 1983;5(2 Pt 2):I184-91.

Sign-in to see more